Teva Pharmaceutical Industries Ltd (TEVA) shareholders
TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30119% above fair value
$43.65+0.41 (+0.95%)
Close on Nov 12, 2026Market cap $50.87BP/E 72.8Yield –
Ownership
Who owns Teva Pharmaceutical Industries's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 65 sales
Net sold $125.65M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Abigail P. Johnson Joint filing with FMR LLC (7.20%) | 81,983,229 | 7.20% | 13G (passive) amendment | Dec 31, 2024 |
| Harel Insurance Investments & Financial Services Ltd | 72,325,555 | 6.30% | 13G (passive) amendment | Dec 31, 2025 |
| Harel Insurance Investments & Financial Services Ltd. | 70,418,201 | 6.00% | 13G (passive) amendment | Sep 30, 2026 |
| Migdal Insurance & Financial Holdings Ltd | 61,689,363 | 5.37% | 13G (passive) | Dec 31, 2025 |
| Menora Mivtachim Holdings Ltd | 57,395,173 | 5.00% | 13G (passive) | Jul 16, 2025 |
| Phoenix Financial Ltd. | 57,383,158 | 5.00% | 13G (passive) | Jul 14, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Richard Daniell | EVP, Europe Commercial | 55,755 | 0.00% | Nov 12, 2026 |
| Amir Weiss | Chief Accounting Officer | 3,537 | 0.00% | Nov 12, 2026 |
| Dov Bergwerk | Interim Chief Legal Officer | 11,943 | 0.00% | Nov 12, 2026 |
| Richard D. Francis | President and CEO | 927,529 | 0.08% | Nov 12, 2026 |
| Mark Sabag | See "Remarks" | 80,760 | 0.01% | Nov 12, 2026 |
| Brian Savage | Interim Chief Legal Officer | 15,842 | 0.00% | Sep 22, 2026 |
| Evan Lippman | EVP, Business Development | 25,591 | 0.00% | Aug 19, 2026 |
| Placid Jover | "See ""Remarks""" | 19,601 | 0.00% | Aug 5, 2026 |
| Eric A. Hughes | "See ""Remarks""" | 134,877 | 0.01% | Aug 5, 2026 |
| Matthew Shields | EVP, Global Operations | 0 | – | Jun 22, 2026 |
| Eliyahu Sharon Kalif | EVP, Chief Financial Officer | 65,621 | 0.01% | Jun 16, 2026 |
| Christine Fox | EVP, U.S. Commercial | 63,647 | 0.01% | May 4, 2026 |
| David R. McAvoy | EVP, Chief Legal Officer | 13,027 | 0.00% | Sep 9, 2025 |
| David J. Brailer | Director | – | – | Nov 12, 2026 |
| Roberto Mignone | Director | 119,807 | 0.01% | Sep 22, 2026 |
| Ronit Satchi-Fainaro | Director | 111,986 | 0.01% | Aug 25, 2026 |
| Tal Zvi Zaks | Director | 73,247 | 0.01% | Aug 10, 2026 |
| Perry Nisen | Director | 119,807 | 0.01% | Jun 8, 2026 |
| Sol J. Barer | Director | 448,011 | 0.04% | Jun 8, 2026 |
| Rosemary A. Crane | Director | 127,739 | 0.01% | Jun 8, 2026 |
| Chen Lichtenstein | Director | 19,296 | 0.00% | Jun 8, 2026 |
| Gerald M. Lieberman | Director | 130,149 | 0.01% | Jun 8, 2026 |
| Amir Elstein | Director | 2,118,455 | 0.18% | Jun 8, 2026 |
| Varda Shalev | Director | 22,504 | 0.00% | Jun 9, 2025 |
| Janet S. Vergis | Director | 73,697 | 0.01% | Jun 9, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Mark Sabag See "Remarks" | Nov 12, 2026 | Sale | −44,710 | $44.14 | $1.97M | 80,760 |
| Mark Sabag See "Remarks" | Nov 12, 2026 | Option exercise | +44,710 | $34.90 | $1.56M | 125,470 |
| Richard Daniell EVP, Europe Commercial | Nov 11, 2026 | Sale | −20,003 | $42.80 | $856.15K | 55,755 |
| Richard Daniell EVP, Europe Commercial | Nov 11, 2026 | Option exercise | +20,003 | $34.70 | $694.10K | 75,758 |
| Richard D. Francis President and CEO | Nov 10, 2026 | Sale(10b5-1 plan) | −250,000 | $42.24 | $10.56M | 927,529 |
| Richard Daniell EVP, Europe Commercial | Nov 9, 2026 | Sale | −25,000 | $42.91 | $1.07M | 55,755 |
| Richard Daniell EVP, Europe Commercial | Nov 9, 2026 | Option exercise | +25,000 | $34.70 | $867.50K | 80,755 |
| Amir Weiss Chief Accounting Officer | Nov 9, 2026 | Sale | −9,534 | $43.03 | $410.24K | 3,537 |
| Amir Weiss Chief Accounting Officer | Nov 9, 2026 | Sale | −7,093 | $43.03 | $305.25K | 13,071 |
| Amir Weiss Chief Accounting Officer | Nov 9, 2026 | Sale | −662 | $43.15 | $28.57K | 20,164 |
| Amir Weiss Chief Accounting Officer | Nov 9, 2026 | Option exercise | +7,755 | $34.70 | $269.10K | 20,826 |
| Mark Sabag See "Remarks" | Nov 5, 2026 | Sale | −46,000 | $41.93 | $1.93M | 80,760 |
| Mark Sabag See "Remarks" | Nov 5, 2026 | Option exercise | +46,000 | $34.90 | $1.61M | 126,760 |
| Dov Bergwerk Interim Cheif Legal Officer | Nov 4, 2026 | Sale | −8,755 | $41.72 | $365.26K | 11,943 |
| Dov Bergwerk Interim Cheif Legal Officer | Nov 4, 2026 | Option exercise | +8,755 | $28.98 | $253.72K | 20,698 |
| Dov Bergwerk Interim Cheif Legal Officer | Nov 4, 2026 | Sale | −17,505 | $41.72 | $730.31K | 11,943 |
| Dov Bergwerk Interim Cheif Legal Officer | Nov 4, 2026 | Option exercise | +17,505 | $34.70 | $607.42K | 29,448 |
| Brian Savage Interim Chief Legal Officer | Sep 18, 2026 | Option exercise | +4,503 | $34.70 | $156.25K | 15,842 |
| Brian Savage Interim Chief Legal Officer | Sep 18, 2026 | Sale | −4,503 | $38.69 | $174.22K | 11,339 |
| Brian Savage Interim Chief Legal Officer | Sep 18, 2026 | Sale | −2,525 | $39.15 | $98.85K | 8,814 |
| Brian Savage Interim Chief Legal Officer | Sep 18, 2026 | Sale | −314 | $38.70 | $12.15K | 8,500 |
| Roberto Mignone Director | Sep 18, 2026 | Sale | −367,600 | $39.06 | $14.36M | 0 |
| Amir Weiss Chief Accounting Officer | Aug 21, 2026 | Sale | −6,945 | $37.61 | $261.20K | 13,071 |
| Amir Weiss Chief Accounting Officer | Aug 21, 2026 | Sale | −2,500 | $37.63 | $94.08K | 13,071 |
| Amir Weiss Chief Accounting Officer | Aug 21, 2026 | Option exercise | +2,500 | $19.61 | $49.03K | 15,571 |
| Ronit Satchi-Fainaro Director | Aug 21, 2026 | Sale | −415 | $37.25 | $15.46K | 111,986 |
| Evan Lippman EVP, Business Development | Aug 17, 2026 | Sale(10b5-1 plan) | −18,600 | $36.57 | $680.20K | 25,591 |
| Tal Zvi Zaks Director | Aug 5, 2026 | Sale | −17 | $34.87 | $593 | 73,247 |
| Eric A. Hughes "See ""Remarks""" | Aug 3, 2026 | Sale(10b5-1 plan) | −25,578 | $34.88 | $892.16K | 134,877 |
| Eric A. Hughes "See ""Remarks""" | Aug 3, 2026 | Option exercise | +52,744 | – | – | 160,455 |
| Placid Jover "See ""Remarks""" | Aug 3, 2026 | Option exercise | +12,827 | – | – | 19,601 |
| Placid Jover "See ""Remarks""" | Aug 3, 2026 | Sale(10b5-1 plan) | −12,827 | $34.88 | $447.41K | 6,774 |
| Matthew Shields EVP, Global Operations | Jun 18, 2026 | Sale | −9,989 | $32.19 | $321.55K | 0 |
| Eliyahu Sharon Kalif EVP, Chief Financial Officer | Jun 11, 2026 | Sale(10b5-1 plan) | −106,563 | $34.10 | $3.63M | 65,621 |
| Roberto Mignone Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 119,807 |
| Rosemary A. Crane Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 127,739 |
| Richard D. Francis President and CEO | Jun 5, 2026 | Option exercise | +13,043 | – | – | 1,183,682 |
| Richard D. Francis President and CEO | Jun 5, 2026 | Sale(10b5-1 plan) | −6,153 | $34.35 | $211.36K | 1,177,529 |
| Ronit Satchi-Fainaro Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 112,401 |
| Gerald M. Lieberman Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 130,149 |
| Amir Elstein Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 2,118,455 |
| Perry Nisen Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 119,807 |
| Chen Lichtenstein Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 19,296 |
| Tal Zvi Zaks Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 73,264 |
| Sol J. Barer Director | Jun 5, 2026 | Option exercise | +21,739 | – | – | 448,011 |
| Matthew Shields EVP, Global Operations | Jun 3, 2026 | Sale(10b5-1 plan) | −16,195 | $32.87 | $532.33K | 9,989 |
| Matthew Shields EVP, Global Operations | Jun 3, 2026 | Option exercise | +16,195 | – | – | 26,184 |
| Eliyahu Sharon Kalif EVP, Chief Financial Officer | May 14, 2026 | Sale(10b5-1 plan) | −153,251 | $35.61 | $5.46M | 172,184 |
| Evan Lippman EVP, Business Development | May 14, 2026 | Sale(10b5-1 plan) | −35,912 | $35.58 | $1.28M | 44,191 |
| Evan Lippman EVP, Business Development | May 14, 2026 | Option exercise | +11,841 | – | – | 11,841 |
| Evan Lippman EVP, Business Development | May 14, 2026 | Sale(10b5-1 plan) | −5,746 | $35.58 | $204.44K | 6,095 |
| Evan Lippman EVP, Business Development | May 14, 2026 | Option exercise | +74,008 | – | – | 80,103 |
| Amir Weiss Chief Accounting Officer | May 6, 2026 | Sale | −10,679 | $36.00 | $384.44K | 20,016 |
| Richard Daniell EVP, Europe Commercial | May 5, 2026 | Sale | −30,000 | $35.40 | $1.06M | 55,755 |
| Mark Sabag "See ""Remarks""" | May 1, 2026 | Sale | −144,180 | $34.99 | $5.04M | 80,760 |
| Christine Fox EVP, U.S. Commercial | Apr 30, 2026 | Sale | −21,258 | $35.31 | $750.62K | 63,647 |
| Mark Sabag "See ""Remarks""" | Mar 17, 2026 | Sale | −62,102 | $30.14 | $1.87M | 224,940 |
| Richard D. Francis President and CEO | Mar 5, 2026 | Sale(10b5-1 plan) | −20,025 | $31.67 | $634.19K | 1,170,639 |
| Richard D. Francis President and CEO | Mar 5, 2026 | Option exercise | +42,452 | – | – | 1,190,664 |
| Matthew Shields EVP, Global Operations | Mar 5, 2026 | Option exercise | +17,295 | – | – | 27,284 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
2.39%
28M shares short
Days to cover
5.3
At 5M shares a day
Change since last report
-1.2%
From 28M shares
Short volume, 20 days
27.3%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Teva Pharmaceutical Industries's stock actually held short. Settlement fails (shares not delivered on time) peaked at 443,776 shares on Sep 25, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Richard D. Francis Officer | Nov 10, 2026 | 250,000 | $10.74M | Nov 10, 2026 | Vesting of restricted share units |
| Richard Daniell Officer, EXECUTIVE VP EUROPEAN COMMERCIAL | Nov 9, 2026 | 25,000 | $1.07M | Nov 9, 2026 | STOCK OPTION EXERCISE AND SALE |
| Mark Sabag Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL | Nov 5, 2026 | 46,000 | $1.93M | Nov 5, 2026 | STOCK OPTION EXERCISE AND SALE |
| Dov Bergwerk Senior VP General Counsel Corporate Secretary | Nov 4, 2026 | 26,260 | $1.10M | Nov 4, 2026 | STOCK OPTION EXERCISE AND SALE |
| Brian Savage Officer, CHIEF LEGAL OFFICER | Sep 21, 2026 | 7,028 | $273.06K | Sep 18, 2026 | SHARES FROM ROLLOVER |
| Bridger Management, LLC (1) Shareholder | Sep 18, 2026 | 367,600 | $14.41M | Sep 18, 2026 | See Remark 2 |
| Evan Lippman Officer, EVP BUSINESS DEVELOPMENT | Aug 17, 2026 | 18,600 | $680.29K | Aug 17, 2026 | Shares from Rollover, ADR |
| Eric A. Hughes Executive VP Global R&D and Chief Med Officer | Aug 3, 2026 | 25,578 | $892.05K | Aug 3, 2026 | Restricted Share Unit Award Vesting |
| Placid Jover Executive VP, Chief HR Officer | Aug 3, 2026 | 12,827 | $447.35K | Aug 3, 2026 | Restricted Share Unit Award Vesting |
| Matthew Shields Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS | Jun 18, 2026 | 9,989 | $321.55K | Jun 18, 2026 | SHARES FROM ROLLOVER |
| Eliyahu Sharon Kalif Officer, EVP CHIEF FINANCIAL OFFICER | Jun 11, 2026 | 106,563 | $3.63M | Jun 11, 2026 | SHARES FROM ROLLOVER |
| Richard D. Francis Officer, PRESIDENT AND CEO | Jun 5, 2026 | 6,153 | $211.36K | Jun 5, 2026 | RESTRICTED SHARE UNIT AWARD VESTING |
| Matthew Shields Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS | Jun 3, 2026 | 16,195 | $532.33K | Jun 3, 2026 | RESTRICTED SHARE UNIT AWARD VESTING |
| Evan Lippman Officer, EXECUTIVE VP BUSINESS DEVELOPMENT | May 14, 2026 | 41,658 | $1.48M | May 14, 2026 | RESTRICTED SHARE UNIT AWARD VESTING |
| Eliyahu Sharon Kalif Officer, EVP CHIEF FINANCIAL OFFICER | May 14, 2026 | 153,251 | $5.46M | May 14, 2026 | SHARES FROM ROLLOVER |
See a number that looks wrong?